Host cell proteins essentially refer to the heterogeneous group of proteins derived from host cells such as E-coli, yeast, and mammal, among others. Identification and quantification of host cell contaminants are essential in the development of biopharmaceuticals. Host cell contaminant testing is the study of biologics from living sources such as bacteria, yeasts, and fungi. The process is used for the research and development process in acute diseases such as cancer.
MARKET DYNAMICS
The increasing number of research activities associated with the testing and the rising number of regulatory approvals related to the testing equipment will propel the host cell contaminant testing market's growth. However, immunogenic reactions associated with host cell proteins can hinder the growth of the market.
MARKET SCOPE
The "Host Cell Contaminant Testing Market Analysis to 2028" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of host cell contaminant testing market with detailed market segmentation with type and application. The host cell contaminant testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in host cell contaminant testing market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The host cell contaminant testing market is segmented on the basis of type and application. On the basis of type, the host cell contaminant testing market is divided into microbial, mammalian and others. Based on application, the host cell contaminant testing market can be segmented research and development and clinical applications.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the host cell contaminant testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The host cell contaminant testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyses factors affecting host cell contaminant testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the host cell contaminant testing market in these regions.
MARKET PLAYERS
The report covers key developments in host cell contaminant testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from host cell contaminant testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for host cell contaminant testing in the global market. Below mentioned is the list of few companies engaged in the host cell contaminant testing market.
The report also includes the profiles of key players in host cell contaminant testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- GE Healthcare (General Electric Company)
- Thermo Fisher Scientific
- BioGenes GmbH
- Molecular Devices, LLC
- ForteBio (Sartorius AG)
- Bio-Rad Laboratories, Inc.
- Cygnus Technologies Inc.
- Cisbio Bioassays
- ProteinSimple, Inc. (Bio-Techne Corporation)
- Enzo Life Sciences, Inc.